Consensus statements have been developed for screening, diagnosis, and treatment of rheumatoid arthritis-associated interstitial lung disease.

In cancer-related pain, routine opioid use was not associated with clinically meaningful alterations in pain thresholds.

The Bodily Sensations Interpretation Questionnaire and Word Association Task show strong psychometric performance in chronic pain assessment.

Zoryve (roflumilast) cream 0.3% for the topical treatment of plaque psoriasis in patients ages 2 years and older receives FDA approval.

Challenging patient interactions can be an adverse influence on the emotions and stress level of emergency physicians.

Having two or more comorbidities is associated with faster radiographic progression in patients with ankylosing spondyloarthritis.

Most adults in the US report use social media for health-related engagement, such as research or sharing personal experiences.

Postoperative opioid dispensing rates and dosages among Medicaid beneficiaries declined significantly across most surgical procedures from 2016 to 2022.

A little over 30% of pediatric surgery patients are prescribed opioids when they are discharged following surgery.

The FDA has accepted for review a Biologics License Application for ReNu, an amniotic suspension allograft, to treat symptomatic knee osteoarthritis pain.

Certain neurologic conditions, like epilepsy or stroke, appear to share a bidirectional association with traumatic brain injury.

Xtoro ® (finafloxacin otic suspension), 0.3% is now available for the treatment of acute otitis externa (AOE) caused by susceptible strains of Pseudomonas aeruginosa and Staphylo ...